Cite

HARVARD Citation

    Tighiouart, M. et al. (2018). A Bayesian adaptive design for cancer phase I trials using a flexible range of doses. Journal of biopharmaceutical statistics. 28 (3), pp. 562-574. [Online]. 
  
Back to record